Vivesto
8.40 SEK
0.00 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
+6.87 %
+0.84 %
-28.51 %
-59.28 %
-59.19 %
-65.65 %
-96.86 %
-99.47 %
Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
93M SEK
Turnover
70.16K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
13/8
2026
Interim report Q2'26
12/11
2026
Interim report Q3'26
11/2
2027
Annual report '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Vivesto announces timetable for reverse share split
DNB Carnegie Access: Vivesto: Purring along – Q1 review
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools